HHS Wants 3rd Circ. To Revive Drug Discount Violation Notice

By P.J. D'Annunzio · August 11, 2022, 8:59 PM EDT

The U.S. Department of Health and Human Services on Thursday asked the Third Circuit to reinstate an enforcement letter to pharmaceutical giant AstraZeneca accusing it of going against a federal discount...

To view the full article, register now.

Documents

Case Information

Case Title

AstraZeneca Pharmaceuticals LP v. Secretary United States Department of Health and H, et al

Case Number

22-1676

Court

Appellate - 3rd Circuit

Nature of Suit

2899 APA Review/Appeal

Date Filed

April 15, 2022